T. McKearn

发表

Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.

V. L. Alvarez, V L Alvarez, A D Lopes, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Cost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy

C. Cogle, S. Mukherjee, T. Bentley, 2016, Expert review of pharmacoeconomics & outcomes research.

Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy

T. McKearn, T. Mckearn, 1993, Cancer.

Site-specifically modified 111In labelled antibodies give low liver backgrounds and improved radioimmunoscintigraphy.

V. L. Alvarez, J. Rodwell, C. Lee, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Site-specifi'c covalent modification of monoclonal antibodies: In vitro and in vivo evaluations (antibody modification/glycoprotein modification/tumor localization/nuclear lnaging/lmmunoscintigraphy)

V. L. Alvarez, J. Henry, J. Rodwell, 2016 .

Selective suppression of reactivity to rat histocompatibility antigens by hybridoma antibodies.

F. Fitch, M. Sarmiento, F. Stuart, 1978, Current topics in microbiology and immunology.

Immunohistochemical application of monoclonal antibodies against myelin basic protein and neurofilament triple protein subunits: advantages over antisera and technical limitations.

J. Trojanowski, V. Lee, N. Gonatas, 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Site-specific modification of monoclonal antibodies. Studies of 111indium-labeled antibodies using nude mouse xenograft systems.

V. L. Alvarez, J. Rodwell, C. Lee, 1988, Targeted diagnosis and therapy.

Monoclonal antibody directed to a B-cell antigen present in rats, mice, and humans.

R. Kennett, D. Gasser, T. McKearn, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of mannosidase in hybridomas yields monoclonal antibodies with greater capacity for carbohydrate labeling.

J. Rodwell, T. McKearn, M. Ultee, 1988, Clinical chemistry.

Antireceptor Antiserum Causes Specific Inhibition of Reactivity to Rat Histocompatibility Antigens

T. McKearn, T. Mckearn, 1974, Science.

Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens.

F. Fitch, F. Stuart, T. McKearn, 1974, Journal of immunology.

Monoclonal rat anti-major histocompatibility complex antibodies display specificity for rat, mouse, and human target cells

D. Wilson, T. McKearn, H. C. Boyd, 1980, The Journal of experimental medicine.

Properties of Rat Anti‐MHC Antibodies Produced by Cloned Rat‐Mouse Hybridomas

F. Fitch, M. Sarmiento, F. Stuart, 1979, Immunological reviews.

Monoclonal rat anti-MHC alloantibodies detectHLA-linked polymorphisms in humans

R. Spielman, T. McKearn, H. C. Boyd, 2005, Immunogenetics.

A monoclonal antibody discriminating between subsets of T and B cells.

J. Sprent, T. McKearn, F. W. Symington, 1981, Journal of immunology.

Anti-receptor antibody and resistance to graft-versus-host disease

F. Fitch, F. Stuart, T. McKearn, 1974, Nature.

Urinary acidification in turtle bladder is due to a reversible proton-translocating ATPase "

Gasser, T. McKearn, L. David, 2022 .

Immunological memory is regulated in the enhanced rat renal allograft recipient

F. Fitch, F. Stuart, T. McKearn, 1978, Nature.

Monoclonal Antibodies and Functional Cell Lines

R. Kennett, K. Bechtol, T. McKearn, 1984, Springer US.

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.

William Berry, Oliver Sartor, J Alfred Witjes, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Suppression of Rat Renal Allograft Rejection by Antigen and Antibody

F. Fitch, F. Stuart, T. McKearn, 1980, Immunological reviews.

Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.

F. Stuart, T. McKearn, A. Holter, 1973, Surgical forum.

Class I major histocompatibility gene products of the brown Norway rat display two major antigenic regions.

D. Klinman, T. McKearn, D. Smilek, 1982, Journal of immunology.

Incidence and Treatment of Myelodysplastic Syndrome in the US: Treatment Approaches, Optimization of Care and the Need for Additional Therapeutic Agents

T. McKearn, L. Silverman, E. Demakos, 2014 .

A monoclonal antibody to an interspecies major histocompatibility determinant inhibits a virus-specific T-cell clone.

J. Bennink, P. Doherty, M. Allouche, 1982, Cellular immunology.

CELLULAR AND HUMORAL IMMUNITY AFTER ALLOGENEIC RENAL TRANSPLANTATION IN THE RAT: V. Appearance of Anti‐Idiotypic Antibody and its Relationship to Cellular Immunity after Treatment with Donor Spleen Cells and Alloantibody

D. Scollard, F. Fitch, F. Stuart, 1976, Transplantation.

Immunological enhancement of renal allografts by antireceptor antibody.

F. Fitch, F. Stuart, T. McKearn, 1976, Surgery.

Treatment Patterns Among Patients with Myelodysplastic Syndromes: Observations of 1st-Line Therapy, Discontinuation and the Need of Additional Therapies

M. Broder, E. Chang, Gordon H. Sun, 2014 .

Linker Technology: Antibody-Mediated Delivery Systems

J. Rodwell, T. McKearn, 1985, Bio/Technology.

A mechanism for the generation of self-tolerance.

T. McKearn, D. Allison, 1975, Journal of theoretical biology.

A rodent class I MHC determinant is shared among many species

T. Potter, T. McKearn, T. Rajan, 2004, Immunogenetics.

Dialyzable serum components can support the growth of hybridoma cell lines in vitro.

D. Klinman, T. McKearn, T. Mckearn, 1981, Journal of immunological methods.